Request for Proposal

Please take a few moments to share some information with us and we will be in touch shortly.

Submit Now
Therapeutic Expertise

Rare Disease

We have good experience in conducting rare disease clinical trials across multiple therapeutic areas, with a strong network of sites, regulatory expertise, and patient engagement strategies to ensure the success of studies in these complex indications.

Experience

  • Primary Sclerosing Cholangitis (PSC): Experience in managing trials for this chronic liver disease with complex endpoints.
  • Primary Biliary Cholangitis (PBC): Expertise in designing trials targeting bile duct inflammation and fibrosis.
  • Nonalcoholic Steatohepatitis (NASH): Conducted clinical trials for novel therapies targeting inflammation and fibrosis.

  • Sjogren's Syndrome: Experience in ophthalmic endpoints for autoimmune-related dry eye disease.
  • Retinoblastoma: Expertise in designing pediatric oncology trials for this rare eye cancer.

  • Glioblastoma - Experience conducting trials for aggressive brain tumors, including novel therapies and combination treatments.
  • Renal Cell Carcinoma (RCC) - Experience with targeted therapies and immunotherapy trials.

  • Established relationships with leading clinical research sites, academic institutions, and key opinion leaders (KOLs).
  • Ability to activate sites quickly, ensuring faster trial initiation and patient enrollment.
  • Global reach with sites across the United States and India, offering diverse patient populations for rare disease studies.

  • Collaborations with patient advocacy organizations to enhance recruitment and retention
  • Access to rare disease patient registries to identify eligible participants
  • Community outreach programs to educate and engage rare disease patients

  • Strong knowledge of FDA, EMA, and CDSCO rare disease regulatory pathways.
  • Support for expanded access and compassionate use programs

  • Clinical trial design & feasibility assessment tailored for small patient populations
  • Biomarker-driven approaches to optimize study outcomes
  • Remote monitoring solutions for patient convenience